Bringing the fundamentals into focus…
Back to CytomX Therapeutics, Inc.
How CytomX Therapeutics, Inc. stacks up
CTMX · against 442 other Healthcare companies of similar size
Profitability
7/ 100
Near the bottom of its peers.
Ranked #412 of 443 · scores higher than 6% of peers
Bars: peers in each 10-point band of the profitability score45 peers with a profitability score of 0–9, including CTMX · Click a bar to see the companies
Why profitability scores 7?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin, return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 93% of peers. Operating margin: -476.2% vs peer median 7.1%
- a lower return on assets: weaker than 81% of peers. Return on assets: -20.9% vs peer median 1.7%
- a lower return on invested capital: weaker than 80% of peers. Return on invested capital: -24.2% vs peer median 4.7%
Metric by metric
Position: dot = CTMX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | CTMX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 415 reported | -24.2% | 1.8% | 21% | 33% | |
| Operating marginHigher is better · 414 reported | -476.2% | 4.6% | 7% | 33% | |
| Return on assetsHigher is better · 439 reported | -20.9% | 0.8% | 21% | 33% | |
| Return on equityHigher is better · 419 reported | -37.8% | 0.7% | 20% | Context only | |
| Gross marginHigher is better · 460 reported | 100.0% | 39.6% | 97% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around CTMX| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 578M USD | 99 | 73 | |
| 1 | 914M USD | 99 | 81 | |
| 1 | 609M USD | 99 | 91 | |
| 405 | 303M USD | 8 | 27 | |
| 405 | 885M USD | 8 | 33 | |
| 412 | 271M USD | 7 | 14 | |
| 412 | 257M USD | 7 | 55 | |
| 412 | 475M USD | 7 | 22 | |
| 412 | 705M USD | 7 | 32 | |
| 416 | 13.0B TWD (≈$402M) | 6 | 49 | |
| 416 | 4.6B SEK (≈$462M) | 6 | 37 | |
| 416 | 888M USD | 6 | 25 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score